Envista Holdings Corporation (NVST)
Does NVST Stock Still Deserve a Place in Your Portfolio?
Envista executes on growth priorities with new products, acquisitions and global expansion, but macro, tariff and currency headwinds remain in focus.
NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?
Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Is NVST Attractive at 15.1x Forward Earnings?
Envista trades at 15.1x forward earnings; Q1 2026 profit surged, and a $24 target hinges on sustaining margins and sales gains.
NVST Stock Explained for 2026 Growth Drivers and Risks
Envista targets margin gains via its Business System while boosting R&D and buybacks, with a $24 6-12 month target vs $22.94.
Here's Why Envista (NVST) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Envista (NVST) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista Q1 Earnings Call Highlights
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
Envista (NVST) International Revenue Performance Explored
Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Why Envista (NVST) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the company's own cost reduction efforts. The company's high-teens EPS growth guidance for the full year is well-supported by new product launches and synergies relating to its latest M&A.
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
